Ionis Pharmaceuticals, Inc. (IONS) Shareholders’ equity 2016–2025
Ionis Pharmaceuticals, Inc. (IONS) shareholders’ equity at each fiscal year-end, per SEC filings.
$489.1MFY2025 · since FY2016: $99.6M → $489.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $489.1M | -16.9% |
| FY2024 | $588.4M | +52.2% |
| FY2023 | $386.7M | -32.5% |
| FY2022 | $572.9M | -25.8% |
| FY2021 | $771.7M | +3.8% |
| FY2020 | $743.3M | -49.5% |
| FY2019 | $1.5B | +40.4% |
| FY2018 | $1.0B | +273.0% |
| FY2017 | $281.0M | +182.2% |
| FY2016 | $99.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice